Acadia Pharmaceuticals Inc

NEW YORK STATE COMMON RETIREMENT FUND ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

52,070

Value ($000)

1,391

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,391	0.0%	52,070	12/31/2025
2025 Q3	11/3/2025	1,192	0.0%	55,874	9/30/2025
2025 Q2	10/8/2025	1,108	0.0%	51,374	6/30/2025
2025 Q1	10/8/2025	853	0.0%	51,374	3/31/2025
2024 Q4	10/8/2025	943	0.0%	51,374	12/31/2024
2024 Q3	10/8/2025	693	0.0%	45,064	9/30/2024
2024 Q2	10/8/2025	937	0.0%	57,664	6/30/2024
2024 Q1	10/8/2025	3,937	0.0%	212,923	3/31/2024
2023 Q4	10/8/2025	6,689	0.0%	213,639	12/31/2023
2023 Q3	10/8/2025	4,866	0.0%	233,509	9/30/2023
2023 Q2	10/8/2025	3,889	0.0%	162,368	6/30/2023
2023 Q1	10/8/2025	1,188	0.0%	63,131	3/31/2023
2022 Q4	10/8/2025	1,365	0.0%	85,735	12/31/2022
2022 Q3	11/8/2022	1,403	0.0%	85,779	9/30/2022
2022 Q2	8/4/2022	1,116	0.0%	79,233	6/30/2022
2022 Q1	7/1/2022	2,090	0.0%	86,287	3/31/2022
2021 Q4	2/2/2022	2,012	0.0%	86,210	12/31/2021
2021 Q3	11/2/2021	1,436	0.0%	86,432	9/30/2021
2021 Q2	8/2/2021	2,480	0.0%	101,700	6/30/2021
2021 Q1	5/11/2021	3,130	0.0%	121,300	3/31/2021
2020 Q4	2/8/2021	7,661	0.0%	143,300	12/31/2020
2020 Q3	11/5/2020	6,596	0.0%	159,900	9/30/2020
2020 Q2	8/7/2020	8,755	0.0%	180,630	6/30/2020
2020 Q1	5/6/2020	4,684	0.0%	110,865	3/31/2020
2019 Q4	2/5/2020	5,253	0.0%	122,780	12/31/2019